$SDCH
SideChannel Inc

2023 Q3 Form 10-K Financial Statement

#000149315223046278 Filed on December 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 2022
Revenue $1.659M $6.572M $4.789M
YoY Change -65.35% 37.23% 23845.0%
Cost Of Revenue $803.0K $3.240M $2.468M
YoY Change -67.46% 31.28%
Gross Profit $856.0K $3.332M $2.321M
YoY Change -63.11% 43.56% 11505.0%
Gross Profit Margin 51.6% 50.7% 48.47%
Selling, General & Admin $985.0K $4.923M $1.849M
YoY Change -288.46% 166.25% -31.26%
% of Gross Profit 115.07% 147.75% 79.66%
Research & Development $186.0K $669.0K $178.0K
YoY Change -165.53% 275.84% -71.29%
% of Gross Profit 21.73% 20.08% 7.67%
Depreciation & Amortization $2.000K $2.000K $46.00K
YoY Change -95.65% -95.65%
% of Gross Profit 0.23% 0.06% 1.98%
Operating Expenses $1.171M $10.75M $13.92M
YoY Change -245.2% -22.77% 320.39%
Operating Profit -$315.0K -$7.414M -$11.59M
YoY Change -110.07% -36.05% 252.4%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $7.000K $29.00K $13.00K
YoY Change -46.15% 123.08% 333.33%
Pretax Income -$5.248M -$7.385M -$11.58M
YoY Change -40.01% -36.23% 273.58%
Income Tax -$379.0K -$379.0K $195.0K
% Of Pretax Income
Net Earnings -$4.869M -$7.006M -$11.78M
YoY Change -45.56% -40.51% 279.87%
Net Earnings / Revenue -293.49% -106.6% -245.9%
Basic Earnings Per Share -$0.04 -$0.14
Diluted Earnings Per Share -$0.02 -$0.04 -$0.14
COMMON SHARES
Basic Shares Outstanding 213.6M shares 175.3M shares 82.00M shares
Diluted Shares Outstanding 175.3M shares 82.00M shares

Balance Sheet

Concept 2023 Q3 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.053M $1.053M $3.030M
YoY Change -65.25% -65.25% -47.58%
Cash & Equivalents $1.100M $3.030M
Short-Term Investments
Other Short-Term Assets $561.0K $561.0K $500.0K
YoY Change 12.2% 12.2% 8.7%
Inventory
Prepaid Expenses $381.0K
Receivables $834.0K $834.0K $612.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.448M $2.448M $4.142M
YoY Change -40.9% -40.9% -33.62%
LONG-TERM ASSETS
Property, Plant & Equipment $30.00K $30.00K
YoY Change
Goodwill $1.356M
YoY Change -3.14%
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets $150.0K $150.0K $330.0K
YoY Change -54.55% -54.55% -35.29%
Total Long-Term Assets $1.536M $1.536M $6.626M
YoY Change -76.82% -76.82% 1199.22%
TOTAL ASSETS
Total Short-Term Assets $2.448M $2.448M $4.142M
Total Long-Term Assets $1.536M $1.536M $6.626M
Total Assets $3.984M $3.984M $10.77M
YoY Change -63.0% -63.0% 59.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $613.0K $613.0K $786.0K
YoY Change -22.01% -22.01% -46.16%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $50.00K $50.00K $50.00K
YoY Change 0.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $954.0K $954.0K $1.161M
YoY Change -17.83% -17.83% -22.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $954.0K $954.0K $1.161M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $954.0K $954.0K $1.372M
YoY Change -30.47% -30.47% -7.92%
SHAREHOLDERS EQUITY
Retained Earnings -$18.94M
YoY Change 58.71%
Common Stock $214.0K
YoY Change 43.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.030M $3.030M $9.396M
YoY Change
Total Liabilities & Shareholders Equity $3.984M $3.984M $10.77M
YoY Change -63.0% -63.0% 59.53%

Cashflow Statement

Concept 2023 Q3 2023 2022
OPERATING ACTIVITIES
Net Income -$4.869M -$7.006M -$11.78M
YoY Change -45.56% -40.51% 279.87%
Depreciation, Depletion And Amortization $2.000K $2.000K $46.00K
YoY Change -95.65% -95.65%
Cash From Operating Activities -$385.0K -$1.945M -$396.0K
YoY Change -121.4% 391.16% -89.09%
INVESTING ACTIVITIES
Capital Expenditures $8.000K $32.00K
YoY Change
Acquisitions -$3.589M
YoY Change
Other Investing Activities $0.00 $0.00 $3.589M
YoY Change -100.0% -100.0%
Cash From Investing Activities -$8.000K -$32.00K $3.589M
YoY Change -100.22% -100.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -$511.0K
YoY Change -100.0% -106.13%
NET CHANGE
Cash From Operating Activities -385.0K -$1.945M -$396.0K
Cash From Investing Activities -8.000K -$32.00K $3.589M
Cash From Financing Activities 0.000 -$511.0K
Net Change In Cash -393.0K -$1.977M $2.682M
YoY Change -108.06% -173.71%
FREE CASH FLOW
Cash From Operating Activities -$385.0K -$1.945M -$396.0K
Capital Expenditures $8.000K $32.00K
Free Cash Flow -$393.0K -$1.977M -$396.0K
YoY Change 399.24% -89.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001022505
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
CY2023 SDCH Increase Decrease In Unbilled Revenue
IncreaseDecreaseInUnbilledRevenue
usd
CY2022 SDCH Increase Decrease In Unbilled Revenue
IncreaseDecreaseInUnbilledRevenue
usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023 SDCH Equity Redemptions Related To Financing Activies
EquityRedemptionsRelatedToFinancingActivies
usd
CY2023 SDCH Equity Distributions Related To Financing Activies
EquityDistributionsRelatedToFinancingActivies
usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023 SDCH Equity Redemption With Note Payable
EquityRedemptionWithNotePayable
usd
CY2022 SDCH Stock Based Compensation Included In Accounts Payable And Accrued Liabilities
StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
usd
CY2023 SDCH Assets Acquired And Liabilities Assumed
AssetsAcquiredAndLiabilitiesAssumed
usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2022Q3 SDCH Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsOutstandingWeightedAverageExercisePriceExercised
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2023 SDCH Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsOutstandingWeightedAverageExercisePriceExercised
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
pure
CY2022 SDCH Effective Income Tax Rate Reconciliation Nondeductible Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleMealsAndEntertainment
pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-28745
CY2023 dei Entity Registrant Name
EntityRegistrantName
SideChannel, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0837077
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
146 Main Street
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 405
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Worcester
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01608
CY2023 dei City Area Code
CityAreaCode
(508)
CY2023 dei Local Phone Number
LocalPhoneNumber
925-0114
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
7800000 usd
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
214117267 shares
CY2023 dei Auditor Firm
AuditorFirmId
587
CY2023 dei Auditor Name
AuditorName
RBSM LLP
CY2023 dei Auditor Location
AuditorLocation
Las Vegas, Nevada
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1053000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3030000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
834000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
612000 usd
CY2023Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2022Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
180000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
381000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
320000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2448000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
4142000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1356000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
1356000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4940000 usd
CY2023Q3 us-gaap Deferred Costs
DeferredCosts
150000 usd
CY2022Q3 us-gaap Deferred Costs
DeferredCosts
330000 usd
CY2023Q3 us-gaap Assets
Assets
3984000 usd
CY2022Q3 us-gaap Assets
Assets
10768000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
613000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
786000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
11000 usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
195000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
954000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1161000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
211000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
954000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1372000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
100 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
100 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213854781 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
148724056 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
148724056 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
214000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
149000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21755000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21180000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18939000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11933000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9396000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3984000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10768000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6572000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4789000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
3240000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
2468000 usd
CY2023 us-gaap Gross Profit
GrossProfit
3332000 usd
CY2022 us-gaap Gross Profit
GrossProfit
2321000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3586000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1482000 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1337000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
367000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
669000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
178000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5702000 usd
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4940000 usd
CY2023 us-gaap Acquisition Costs
AcquisitionCosts
214000 usd
CY2022 us-gaap Acquisition Costs
AcquisitionCosts
6186000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
10746000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
13915000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-7414000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-11594000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7385000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11581000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-379000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7006000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11776000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175274762 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175274762 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81997953 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81997953 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
427000 usd
CY2022 SDCH Equity Redemptions
EquityRedemptions
-100000 usd
CY2022 SDCH Equity Distributions
EquityDistributions
-461000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
43000 usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
30000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
6061000 usd
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
15172000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11776000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9396000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9396000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
66000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
360000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
214000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7006000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3030000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7006000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11776000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
182000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
46000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
405000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
73000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27000 usd
CY2023 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
214000 usd
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6061000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5702000 usd
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4940000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
225000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
461000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
61000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-15000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-547000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-18000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
150000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-65000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1945000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-396000 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-3589000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3589000 usd
CY2022 SDCH Equity Redemptions Related To Financing Activies
EquityRedemptionsRelatedToFinancingActivies
50000 usd
CY2022 SDCH Equity Distributions Related To Financing Activies
EquityDistributionsRelatedToFinancingActivies
461000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-511000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1977000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2682000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3030000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
348000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1053000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3030000 usd
CY2023 SDCH Shares Issued For Services Non Cash Investing And Financing Activities
SharesIssuedForServicesNonCashInvestingAndFinancingActivities
66000 usd
CY2022 SDCH Shares Issued For Services Non Cash Investing And Financing Activities
SharesIssuedForServicesNonCashInvestingAndFinancingActivities
43000 usd
CY2022 SDCH Equity Redemption With Note Payable
EquityRedemptionWithNotePayable
50000 usd
CY2023 SDCH Stock Based Compensation Included In Accounts Payable And Accrued Liabilities
StockBasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
21000 usd
CY2022 SDCH Assets Acquired And Liabilities Assumed
AssetsAcquiredAndLiabilitiesAssumed
11583000 usd
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zuNwXj0uaBG2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zXUUn2Lv9Ke2">Reclassifications</span></b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Certain prior year amounts have been reclassified to be comparable with the current year’s presentation.</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </span></p>
CY2023Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
800000 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
35000000 usd
CY2023 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
4900000 usd
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
7000000.0 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
211000 usd
CY2022Q3 us-gaap Goodwill Fair Value Disclosure
GoodwillFairValueDisclosure
5702000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5700000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
1400000 usd
CY2023Q3 SDCH Percentage Of Accounts Receivable
PercentageOfAccountsReceivable
0.03 pure
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
669000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
82000000.0 shares
CY2023Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q3 SDCH Milestone Revenue
MilestoneRevenue
5500000 usd
CY2022Q3 us-gaap Share Price
SharePrice
0.10
CY2022Q3 SDCH Fair Value Of Closing Shares
FairValueOfClosingShares
6100000 usd
CY2022Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
88400000 usd
CY2022Q3 us-gaap Share Price
SharePrice
0.101
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6200000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130000 usd
CY2023 SDCH Contract With Customer Liability Revenue Deferred
ContractWithCustomerLiabilityRevenueDeferred
553000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
403000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000 usd
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
194000 usd
CY2022 SDCH Contract With Customer Liability Revenue Deferred
ContractWithCustomerLiabilityRevenueDeferred
107000 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
171000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130000 usd
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12000 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022 us-gaap Limited Partners Capital Account Distribution Amount
LimitedPartnersCapitalAccountDistributionAmount
461000 usd
CY2021Q4 us-gaap Limited Partners Capital Account Distribution Amount
LimitedPartnersCapitalAccountDistributionAmount
0 usd
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213854781 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
148724056 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
681000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
2116618 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8000000.0 shares
CY2021Q3 SDCH Reserve Percentage
ReservePercentage
0.05 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8186106 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.10
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
694000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y3M18D
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
100 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
87794000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.56
CY2022Q3 SDCH Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne
P3Y9M25D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
87794000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.56
CY2023 SDCH Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne
P3Y6M25D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
18513000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.20
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
69281000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.39
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y3M21D
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-136000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
136000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-32000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
59000 usd
CY2023 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
-168000 usd
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
195000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-211000 usd
CY2023 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-211000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-379000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2023 SDCH Effective Income Tax Rate Reconciliation Nondeductible Expense Contingent Consideration
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseContingentConsideration
-0.0189 pure
CY2022 SDCH Effective Income Tax Rate Reconciliation Nondeductible Expense Contingent Consideration
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseContingentConsideration
-0.0872 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
-0.0814 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0010 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.0158 pure
CY2023 SDCH Effective Income Tax Rate Reconciliation Nondeductible Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleMealsAndEntertainment
-0.0022 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0302 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0080 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1836 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0484 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0513 pure
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-379000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
27000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
211000 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
36200000 usd
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
525000 usd
CY2023 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period. Future ownership changes may trigger Section 382 and therefore, substantially limit the amount of pre-Combination NOLs that can be utilized annually to offset future taxable income.

Files In Submission

Name View Source Status
sdch-20230930_lab.xml Edgar Link unprocessable
sdch-20230930_pre.xml Edgar Link unprocessable
sdch-20230930_def.xml Edgar Link unprocessable
sdch-20230930_cal.xml Edgar Link unprocessable
0001493152-23-046278-index-headers.html Edgar Link pending
0001493152-23-046278-index.html Edgar Link pending
0001493152-23-046278.txt Edgar Link pending
0001493152-23-046278-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-1_001.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdch-20230930.xsd Edgar Link pending
Show.js Edgar Link pending